Chronic Pelvic Pain Syndrome in Males
Examination of the Efficacy of ESWT (Extracorporeal Shock Wave Therapy) and TENS (Transcutaneous Electrical Nerve Stimulation) in Individuals Receiving Drug Treatment for Chronic Pelvic Pain Syndrome: Randomized Controlled Study
1 other identifier
interventional
38
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of ESWT (Extracorporeal Shock Wave Therapy) and TENS (Transcutaneous Electrical Nerve Stimulation) in individuals diagnosed with chronic pelvic pain syndrome and treated with medication. The study was organized as a randomized controlled trial. The sample size is 30 patients suffering from chronic pelvic pain syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedOctober 16, 2024
October 1, 2024
3 months
March 29, 2024
October 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
VISUAL ANALOUGE SCALE
It evaluates pain intensity grading between 0-10. Higher score shows severe pain.
baseline and immediately after the intervention
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)
This assesses the quality of life. The index has sub dimensions(pain, urinary symptoms, quality of life impact). The score evaluation of the pain scale is between 1 and 21 points, the score evaluation of the urination scale is between 0 and 10 points, and the score evaluation of the quality of life scale is between 0 and 12 points.
baseline and immediately after the intervention
ALGOMETER
This evaluates pain tolerance threshold of the patients.The less score shows pain intolerance.
baseline and immediately after the intervention
Secondary Outcomes (6)
Hospital Anxiety and Depression Scale- HAD
baseline and immediately after the intervention
Nottingham Health Profile-NHP
baseline and immediately after the intervention
Digital Muscle Testing
baseline and immediately after the intervention
Flexibility Measurements
baseline and immediately after the intervention
ROM Assessments
baseline and immediately after the intervention
- +1 more secondary outcomes
Study Arms (2)
GROUP I: TENS
EXPERIMENTALPHYSIOTHERAPY PROGRAM PLUS TENS
GROUP II: ESWT
ACTIVE COMPARATORPHYSIOTHERAPY PROGRAM PLUS ESWT
Interventions
Eligibility Criteria
You may qualify if:
- Aged between 20-40 years old males
- Diagnosis of Chronic Pelvic Pain Syndrome
You may not qualify if:
- Cancer
- Surgery related to pelvic floor
- \. Receiving drug treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Health Sciences in Biruni University
Istanbul, Zeytinburnu, 34010, Turkey (Türkiye)
Related Publications (1)
Schneider MP, Tellenbach M, Mordasini L, Thalmann GN, Kessler TM. Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int. 2013 Jul;112(2):E159-63. doi: 10.1111/bju.12005. Epub 2013 Feb 22.
PMID: 23433012BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 29, 2024
First Posted
April 17, 2024
Study Start
January 1, 2024
Primary Completion
April 4, 2024
Study Completion
August 15, 2024
Last Updated
October 16, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share